P. Woll

发表

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

J. Cave, I. Galea, C. Ottensmeier, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

1477PA NOVEL PHASE II TRIAL OF IPILIMUMAB, CARBOPLATIN AND ETOPOSIDE (ICE) FOR THE FIRST LINE TREATMENT OF EXTENSIVE STAGE SMALL CELL LUNG CANCER (SCLC).

J. Cave, I. Galea, C. Ottensmeier, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant chemotherapy (CT) with doxorubicin and ifosfamide in resected soft tissue sarcoma (STS): Interim analysis of a randomised phase III trial

J. Blay, M. Glabbeke, A. Cesne, 2007 .

S85 British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine combined with cisplatin 50 mg/m2 (GC50) vs cisplatin 80 mg/m2 (GC80) vs carboplatin AUC 6 (GCb6) in advanced NSCLC

D. Dunlop, K. O'Byrne, L. Billingham, 2011, Thorax.

S86 Quality of life in advanced non-small cell lung cancer, effects of cisplatin dose and carboplatin in combination with gemcitabine: results from BTOG2, a British Thoracic Oncology Group phase III trial in 1363 patients

D. Dunlop, K. O'Byrne, M. Nicolson, 2011, Thorax.